Bogdanos D-P, Baum H, Gunsar F, Arioli D, Polymeros D, Ma Y, Burroughs A K, Vergani D
Institute of Liver Studies, King's College Hospital, London, UK.
Scand J Gastroenterol. 2004 Oct;39(10):981-7. doi: 10.1080/00365520410003236.
Primary biliary cirrhosis (PBC) is an immune-mediated chronic cholestatic disease characterized by the presence of antibodies directed predominantly against the E2 subunit of the pyruvate dehydrogenase complex (PDC-E2). What provokes tolerance breakdown in PBC remains to be established, though there is evidence to indicate that microbes may induce anti-mitochondrial antibodies (AMA) through a mechanism of molecular mimicry.
Having found that urease beta (UREB)(22-36) antigen of Helicobacter pylori (HELPY) shares extensive (87%) similarity with PDC-E2(212-226), the major mitochondrial autoepitope, it was hypothesized that this would also lead to cross-reactivity. The UREB/PDC-E2 mimics were thus constructed and tested by ELISA in 112 PBC patients and 114 controls.
Reactivity to PDC-E2(212-226) was found in 104 patients but to UREB(22-36) in only 2. In these two patients, the double reactivity was not cross-reactive. The lack of surface antibody accessibility to UREB(22-36), as demonstrated through three-dimensional model prediction analysis, may explain this unexpected finding. There was some speculation on whether HELPY UREB(22-36) might act as a cross-reactive CD4 T-cell epitope. All seven PBC patients, tested in a standard proliferation assay against PDC-E2(212-226), gave a positive response. All seven were unresponsive to HELPY UREB(22-36). The pattern of reactivity to HELPY antigens by immunoblot was similar between anti-PDC-E2-positive and negative PBC cases, as well as between PBC patients and controls.
Contrary to common belief, extensive sequence homology (molecular mimicry) between self and microbe does not necessarily result in cross-reactivity. It is therefore likely that, when present, cross-reactivity between self and microbes is of biological importance.
原发性胆汁性肝硬化(PBC)是一种免疫介导的慢性胆汁淤积性疾病,其特征是主要存在针对丙酮酸脱氢酶复合体(PDC-E2)E2亚基的抗体。尽管有证据表明微生物可能通过分子模拟机制诱导抗线粒体抗体(AMA),但PBC中导致免疫耐受破坏的原因仍有待确定。
发现幽门螺杆菌(HELPY)的脲酶β(UREB)(22-36)抗原与主要的线粒体自身表位PDC-E2(212-226)具有广泛的(87%)相似性,因此推测这也会导致交叉反应性。于是构建了UREB/PDC-E2模拟物,并通过酶联免疫吸附测定(ELISA)对112例PBC患者和114例对照进行检测。
104例患者对PDC-E2(212-226)有反应,但只有2例对UREB(22-36)有反应。在这两名患者中,双重反应性并非交叉反应性。通过三维模型预测分析表明,UREB(22-36)缺乏表面抗体可及性,这可能解释了这一意外发现。有人猜测HELPY UREB(22-36)是否可能作为交叉反应性CD4 T细胞表位。在针对PDC-E2(212-226)的标准增殖试验中检测的所有7例PBC患者均给出阳性反应。所有7例对HELPY UREB(22-36)均无反应。抗PDC-E2阳性和阴性的PBC病例之间,以及PBC患者和对照之间,通过免疫印迹法对HELPY抗原的反应模式相似。
与普遍看法相反,自身与微生物之间广泛的序列同源性(分子模拟)不一定会导致交叉反应性。因此,当自身与微生物之间存在交叉反应性时,很可能具有生物学重要性。